Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study

James Douglas Thornton,Tyler Varisco,Harshil Patel,Mina Shrestha,Matthew Wanat,Eric Schaefer,Douglas Leslie,Hui Zhao,Randa Al Saadi,Chan Shen
DOI: https://doi.org/10.1136/bmjopen-2023-082339
IF: 3.006
2024-05-31
BMJ Open
Abstract:Objective To evaluate co-prescribing of sedatives hypnotics and opioids. Design Retrospective study evaluating the association of patient characteristics and comorbidities with coprescribing. Setting and participants Using the national Merative MarketScan Database between 2005 and 2018, we identified patients who received an incident sedative prescription with or without subsequent, incident opioid prescriptions within a year of the sedative prescription in the USA. Outcome measures Coprescription of sedative-hypnotics and opioids. Results A total of 2 632 622 patients (mean (SD) age, 43.2 (12.34) years; 1 297 356 (62.5%) female) received incident prescriptions for sedatives over the course of the study period. The largest proportion of sedative prescribing included benzodiazepines (71.1%); however, z-drugs (19.9%) and barbiturates (9%) were also common. About 557 845 (21.2%) patients with incident sedatives also received incident opioid prescriptions. About 59.2% of these coprescribed patients received opioids coprescription on the same day. Multivariate logistic regression findings showed that individuals with a comorbidity index score of 1, 2 or ≥3 (aOR 1.19 (95% CI 1.17 to 1.21), 1.17 (95% C 1.14 to 1.19) and 1.25 (95% C 1.2 to 1.31)) and substance use disorder (1.21 (95% C 1.19 to 1.23)) were more likely to be coprescribed opioids and sedatives. The likelihood of receiving both opioid and sedative prescriptions was lower for female patients (aOR 0.93; 95% CI 0.92 to 0.94), and those receiving a barbiturate (aOR 0.3; 95% CI 0.29 to 0.31) or z-drugs (aOR 0.67; 95% CI 0.66 to 0.68) prescriptions at the index date. Conclusions Coprescription of sedatives with opioids was associated with the presence of comorbidities and substance use disorder, gender and types of sedatives prescribed at the index date. Additionally, more than half of the coprescribing occurred on the same day which warrants further evaluation of current prescribing and dispensing best practice guidelines.
medicine, general & internal
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are to evaluate and describe the trends of combined prescriptions of sedative - hypnotics (including benzodiazepines, barbiturates and Z - drugs) and opioids, the characteristics of patients, and the time frame of the first combined prescription. Specifically, the study aims to: 1. **Evaluate the combined prescriptions of sedative - hypnotics and opioids**: Through a retrospective cohort study, analyze how many of the patients who first used sedative - hypnotics between 2005 and 2018 were prescribed opioids within the following year. 2. **Describe the characteristics of patients with combined prescriptions**: Analyze how factors such as the patient's gender, age, region, comorbidity index, and mental health status affect the likelihood of combined prescriptions. 3. **Determine the time frame of the first combined prescription**: Explore whether combined prescriptions mainly occur on the same day and whether these prescriptions are dispensed at the same pharmacy. ### Research Background Sedative - hypnotics (such as benzodiazepines, barbiturates and Z - drugs) are often used to treat epilepsy, anxiety and insomnia. However, these drugs can inhibit the central nervous system and may lead to severe respiratory depression and even death. When combined with opioids, this risk increases significantly. Therefore, understanding and evaluating the combined prescription patterns of these two drugs are of great significance for reducing potential medical risks. ### Main Findings - **Proportion of combined prescriptions**: Among 2,632,622 patients who first used sedative - hypnotics, approximately 21.2% were prescribed opioids within the following year. - **Time of combined prescriptions**: Approximately 59.2% of combined prescriptions occurred on the same day. - **Influence of patient characteristics**: - **Comorbidity index**: Patients with a higher comorbidity index are more likely to be prescribed in combination. - **Mental health status**: Patients with substance use disorders are more likely to be prescribed in combination, while patients with anxiety, depression or severe mental illness are less likely to be prescribed in combination. - **Gender**: Female patients are less likely to be prescribed in combination. - **Type of sedative - hypnotic**: Patients using barbiturates or Z - drugs are less likely to be prescribed in combination. ### Conclusion This study reveals the common patterns of combined prescriptions of sedative - hypnotics and opioids and their relationship with patient characteristics. In particular, comorbidities and substance use disorders significantly increase the risk of combined prescriptions, while female patients and patients using specific types of sedative - hypnotics (such as barbiturates and Z - drugs) are less likely to be prescribed in combination. In addition, more than half of the combined prescriptions occur on the same day, which suggests that the current prescription and dispensing guidelines need to be further evaluated to reduce potential medical risks.